Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)
Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)
Recruiting · NCT04305769 · Registry updated 2024-10-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT) | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium difficile colitis, Clostridium infectious disease, Digestive System Diseases, Infections, bacterial infectious disease, digestive system disorder, enterocolitis, gastroenteritis, gram-positive bacterial infections, intestinal disorder | Recruiting | Phase 2 | 2024-10-26 | NCT04305769 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Carilion Clinic | 16 |
| University of Southampton | 60 |
| University of Virginia | 201 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Carilion Clinic | Roanoke | United States | 26 |
| UVA Health Systems | Charlottesville | United States | 2 |